SMS Lifesciences Intrinsic Value
SMS Lifesciences (SMSLIFE) median intrinsic value is ₹865.04 from 10 valuation models (range ₹406–₹2453), vs current price ₹1353.50 — -36.1% downside (Trading Above Calculated Value), margin of safety -56.5%. For current market price and key ratios, visit SMSLIFE stock overview.
SMSLIFE Valuation Methods Summary — DCF, Graham Number & P/E
SMS Lifesciences intrinsic value across 10 models vs current price ₹1353.50 — upside/downside and value range per method. Browse SMSLIFE financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹865.04 | ₹692.03 - ₹1038.05 | -36.1% | EPS: ₹39.32, Sector P/E: 22x |
| Book Value Method | asset | ₹1413.33 | ₹1272.00 - ₹1554.66 | +4.4% | Book Value/Share: ₹706.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹2453.33 | ₹2208.00 - ₹2698.66 | +81.3% | Revenue/Share: ₹1226.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1278.83 | ₹1150.95 - ₹1406.71 | -5.5% | EBITDA: ₹40.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1052.16 | ₹841.73 - ₹1262.59 | -22.3% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹406.05 | ₹365.44 - ₹446.66 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹607.49 | ₹546.74 - ₹668.24 | -55.1% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹676.75 | ₹609.08 - ₹744.43 | -50.0% | ROE: 7.5%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹790.69 | ₹711.62 - ₹869.76 | -41.6% | EPS: ₹39.32, BVPS: ₹706.67 |
| Dividend Yield Method | dividend | ₹406.05 | ₹365.44 - ₹446.66 | -70.0% | DPS: ₹1.50, Target Yield: 2.5% |
SMSLIFE Intrinsic Value vs Market Price — All Valuation Models
SMS Lifesciences fair value range ₹406–₹2453 vs current market price ₹1353.50 across 10 valuation models. Compare with SMSLIFE fundamental valuation to assess whether the stock is under or overvalued.
SMSLIFE Intrinsic Value Analysis — Undervalued or Overvalued?
SMS Lifesciences median intrinsic value ₹865.04, current price ₹1353.50 — Trading Above Calculated Value by 36.1%, margin of safety -56.5%.
What is the intrinsic value of SMSLIFE?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of SMS Lifesciences (SMSLIFE) is ₹865.04 (median value). With the current market price of ₹1353.50, this represents a -36.1% variance from our estimated fair value.
The valuation range spans from ₹406.05 to ₹2453.33, indicating ₹406.05 - ₹2453.33.
Is SMSLIFE undervalued or overvalued?
Based on our multi-method analysis, SMS Lifesciences (SMSLIFE) appears to be trading above calculated value by approximately 36.1%.
SMSLIFE Financial Health — Key Ratios vs Industry Benchmarks
SMS Lifesciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.19 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.84 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 7.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.94x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SMSLIFE Cash Flow Quality — Operating & Free Cash Flow
SMS Lifesciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹34 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹24 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹15 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹-11 Cr | ₹-15 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹35 Cr | ₹22 Cr | Positive Free Cash Flow | 8/10 |